NEKTAR THERAPEUTICS's ticker is NKTR and the CUSIP is 640268108. A total of 241 filers reported holding NEKTAR THERAPEUTICS in Q2 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $2,125,000 | +15.4% | 106,238 | -1.9% | 0.68% | +5.9% |
| Q4 2020 | $1,842,000 | -6.8% | 108,342 | -9.1% | 0.64% | -30.4% |
| Q3 2020 | $1,977,000 | -29.7% | 119,198 | -1.8% | 0.92% | -34.5% |
| Q2 2020 | $2,813,000 | +26.8% | 121,439 | -2.3% | 1.41% | +3.7% |
| Q1 2020 | $2,219,000 | -12.8% | 124,292 | +5.4% | 1.36% | +21.7% |
| Q4 2019 | $2,545,000 | +28.7% | 117,910 | +8.6% | 1.11% | +12.3% |
| Q3 2019 | $1,977,000 | -42.3% | 108,540 | +12.8% | 0.99% | -42.2% |
| Q2 2019 | $3,424,000 | – | 96,226 | – | 1.72% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Rhenman & Partners Asset Management AB | 1,350,000 | $22,950,000 | 1.87% |
| MAVERICK CAPITAL LTD | 6,655,625 | $113,146,000 | 1.81% |
| Camber Capital Management LP | 2,500,000 | $42,500,000 | 1.49% |
| Bellevue Group AG | 3,866,258 | $65,726,000 | 0.75% |
| Adero Partners, LLC | 51,500 | $876,000 | 0.75% |
| Goodman Financial Corp | 108,342 | $1,842,000 | 0.64% |
| CM Management, LLC | 35,000 | $595,000 | 0.55% |
| OSTERWEIS CAPITAL MANAGEMENT INC | 424,504 | $7,217,000 | 0.43% |
| RICE HALL JAMES & ASSOCIATES, LLC | 568,379 | $9,662,000 | 0.34% |
| Burleson & Company, LLC | 107,736 | $1,832,000 | 0.32% |